KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Cash & Current Investments (2016 - 2026)

Staar Surgical (STAA) has disclosed Cash & Current Investments for 17 consecutive years, with $187.5 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments fell 18.64% year-over-year to $187.5 million, compared with a TTM value of $187.5 million through Jan 2026, down 18.64%, and an annual FY2026 reading of $187.5 million, down 18.64% over the prior year.
  • Cash & Current Investments was $187.5 million for Q1 2026 at Staar Surgical, down from $192.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $245.1 million in Q1 2024 and bottomed at $187.5 million in Q1 2026.
  • Average Cash & Current Investments over 5 years is $210.2 million, with a median of $207.6 million recorded in 2022.
  • The sharpest move saw Cash & Current Investments grew 25.43% in 2024, then dropped 19.27% in 2025.
  • Year by year, Cash & Current Investments stood at $211.6 million in 2022, then grew by 4.29% to $220.7 million in 2023, then grew by 4.43% to $230.5 million in 2024, then fell by 16.41% to $192.7 million in 2025, then decreased by 2.66% to $187.5 million in 2026.
  • Business Quant data shows Cash & Current Investments for STAA at $187.5 million in Q1 2026, $192.7 million in Q3 2025, and $189.9 million in Q2 2025.